Dulofibrate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDulofibrate
Drug Alias Name度洛贝特dulofibrate杜罗贝特dulofibratodulofibratum
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesterol inhibitorsPeroxisome proliferator-activated receptor α agonists
TargetsCholesterolPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAsta Medica Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsta Medica Ag
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A